Late last month, Lincoln, Nebraska-based Virtual Incision Corporation, a developer of in vivo robots for use in single incision laparoscopic surgery, announced it completed a $2 million Series A financing led by PrairieGold Venture Partners and Bluestem Capital.
According to an October 29th press release from PrairieGold, a Sioux Falls, South Dakota-based early stage venture capital firm, proceeds of the financing will be be used to develop advanced prototypes of the company’s robotic surgical platform.
Also announced was Virtual Incision’s establishment of its corporate headquarters in Lincoln, Nebraska, home to the University of Nebraska–Lincoln out of which the technology is exclusively licensed.
PrairieGold’s press release calls the development of Virtual Incision’s technology an “important step in the evolution toward scarless surgical procedures performed on a robotic platform.” A number of advantages of the technology are then listed, including:
Thanks to our sponsor
- Insertion can be done through a single incision in the navel
- The platform will not require a dedicated operating room or other specialized infrastructure
- The technology utilizes existing tools and techniques surgeons are already familiar with
- The platform will be significantly less expensive than existing robotic alternatives.
To learn more about the future use of the company’s technology, its background and founders (University of Nebraska professors Dr. Shane Farritor and Dr. Dmitry Oleynikov, read the full press release at pgvp.com/news or see: Virtual Incision Corporation Completes $2 Million Series A Financing.
